Medtronic acquires diabetes monitoring tool from Danish company

Medtronic has purchased substantially all glucose monitoring assets from PreciSense, a Horsholm, Denmark-based development company focused on continuous glucose monitoring (CGM) technology. Terms of the acquisition were not disclosed.

This acquisition is an effort to expand Medtronic's CGM pipeline, and develop a new CGM platform to aid development of its ‘closed-loop' system, according to Medtronic's Diabetes Unit President and Senior Vice President Chris O'Connell.

According to the Minneapolis-based Medtronic, CGM is an advancement in diabetes management technology because it shows people their changing glucose levels in real-time. Medtronic has a diabetes management system that integrates CGM with insulin pump therapy, the MiniMed Paradigm Real-Time CGM system. Using algorithms, the company said a closed-loop system is being designed to continuously monitor glucose levels and automatically adjust insulin delivery in patients.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."